Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and CyclophosphamidePaul Shaughnessy, Peter A. McSweeney, Matthew J. Silva et al.|Transplantation and Cellular Therapy|2010Cited by 88
Plerixafor Plus G-CSF Compared to Chemotherapy Plus G-CSF for Mobilization of Autologous CD34+ Cells Resulted in Similar Cost but More Predictable Days of Apheresis and Less Hospitalization.Paul Shaughnessy, Peter A. McSweeney, Miguel Islas‐Ohlmayer et al.|Blood|2009Cited by 8
Plerixafor Plus G-CSF Resulted In Similar Cost But More Predictable Days Of Apheresis Compared To Chemotherapy Plus G-CSF For Mobilization Of Autologous Hematopoietic Stem CellsPaul Shaughnessy, Peter A. McSweeney, Michael B. Maris et al.|Transplantation and Cellular Therapy|2010Cited by 2